Emergent BioSolutions | EBS - PE Price to Earnings

Stock Price
10.93
Daily Change
-0.06 -0.55%
Monthly
-4.96%
Yearly
41.76%
Q1 Forecast
10.65

Emergent BioSolutions reported 14.4 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
ALKERMES USD 14.9 1.11 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin USD 91.05 88.3 Jun/2023
ANI Pharmaceuticals USD 98.67 48.54 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Emergent BioSolutions 14.4 2.25 Sep/2022
Exelixis USD 602.31 586.25 Dec/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Ironwood Pharmaceuticals USD 204.24 88.19 Dec/2024
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Lonza CHF 67.52 12.2 Jun/2024
Merck USD 13.92 5.08 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Pacira USD 29.24 6.15 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
PTC Therapeutics USD 9.98 3.25 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
United Therapeutics USD 15.7 4.24 Sep/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Xoma 52.12 3.09 Sep/2022